Made on
Tilda
A full strategic pitch and three brand-specific assets built from scratch during the application process — including an HTML email template, 7-day content calendar, and a trend-based Facebook ad — all created specifically for Calmerceuticals, not adapted from templates.
The supplement market in Australia is consolidating around credibility. Brands that can prove clinical efficacy — not just claim it — will own the next three years.
Calmerceuticals is positioned exactly right: VERISOL®, liquid format, therapeutic doses. The science is there. The gap is in execution — turning that proof into content that stops a scroll, builds trust in 8 seconds, and converts a sceptical 42-year-old who's been burned by three collagen brands before.
The gap is in execution: turning clinical proof into content that actually stops a scroll, builds trust in 8 seconds, and converts a sceptical 42-year-old who's been burned by three collagen brands before.
— Strategic Assessment, Calmerceuticals ApplicationEach move connects to a specific commercial objective — not general marketing activity. All three can run in parallel within 90 days.
Create a modular content library: 12 core claim graphics (dose, absorption, timeline, VERISOL® vs generic) reusable across all platforms. Estimated output: 60+ pieces of content from one production day.
Launch a 4-week educational series — organic + paid — targeting women 38–52. Most perimenopause supplement marketing is emotional and vague. Win with specificity: named symptoms, named mechanisms, named ingredients at named doses.
Run a 30-day test: retarget video viewers with a sequenced Meta ad (view → education → offer), with a subscription-first CTA. If conversion is below benchmark, identify whether the constraint is creative or landing page.
Every asset below was created from scratch during this application process, using Calmerceuticals' brand voice, colour palette (#610C27, #F5A623, #00A3A1), and product positioning. Not templates. Not samples from another brand.
Full responsive email — header, hero, stats strip, product card, comparison table, testimonial, CTA block, and footer. Built in brand colours (#610C27 maroon, #F5A623 gold, #00A3A1 teal). Mobile-optimised.
Week 1 theme: Pains & Problems — 7 hooks targeting dose scepticism, perimenopause signals, label-dressing, and gut absorption. Each post mapped with hook, brief, platform, and funnel stage.
Uses the '63% of consumers require clinical proof' data angle. Structured as: hook → 3 credibility questions → Calmerceuticals answer → soft CTA. Designed to stop the scroll, qualify the reader, and convert sceptics.
The three-question format pre-qualifies the audience. Anyone who reads to the end already cares about clinical proof — Calmerceuticals' core differentiator. The soft CTA reduces friction for a cold audience who hasn't heard of the brand.
Every asset matches Calmerceuticals' clinical, confident tone with zero generic wellness language — no "miracle", no "magic", no vague timelines.
HTML email, content calendar, and paid social post are each adapted to channel mechanics and audience psychology — not copy-pasted across formats.
Each asset connects to a specific funnel objective: awareness (ad), consideration (calendar), conversion (email). Not content for content's sake.
The Calmerceuticals opportunity is specific and time-sensitive. Three data points drive every strategic recommendation above.
Most perimenopause supplement marketing is emotional and vague. Calmerceuticals has the credentials to win on specificity: named symptoms, named mechanisms, named ingredients at named doses. This is a defensible position competitors without clinical backing cannot replicate.
She has already been burned by three collagen brands. She reads ingredient labels. She Googles clinical studies. She does not respond to aspiration — she responds to evidence. Every piece of content must earn her trust with specifics before asking for anything.
200K–700K TikTok views is a strong organic signal. The gap is conversion: those viewers are not subscribing at the rate the traffic warrants. The sequenced Meta retargeting approach (Move 03) is designed specifically to close this gap — turning passive interest into active trial.
Everything above was created specifically for this brand — not repurposed from another engagement. If you'd like to discuss any of the assets, the strategic recommendations, or what a full 90-day execution plan looks like, reach out directly.